Loading…
Amarin Corporation plc is projected to rise to $18.35 by 2027, a +26% move from its current price of $14.52. AMRN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.31 | $14.53 | $14.75 | +0.07% |
| May 30 | $14.23 | $14.54 | $14.86 | +0.14% |
| May 31 | $14.17 | $14.55 | $14.94 | +0.21% |
| Jun 1 | $14.12 | $14.56 | $15.01 | +0.28% |
| Jun 2 | $14.08 | $14.57 | $15.08 | +0.35% |
| Jun 3 | $14.05 | $14.58 | $15.14 | +0.42% |
| Jun 4 | $14.02 | $14.59 | $15.19 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.02 | $14.59 | $15.19 | +0.49% |
| Week 2 | $13.85 | $14.66 | $15.52 | +0.99% |
| Week 3 | $13.74 | $14.74 | $15.80 | +1.49% |
| Week 4 | $13.66 | $14.81 | $16.05 | +1.99% |
| Week 5 | $13.60 | $14.88 | $16.29 | +2.50% |
| Week 6 | $13.55 | $14.96 | $16.51 | +3.00% |
| Week 7 | $13.51 | $15.03 | $16.72 | +3.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Amarin Corporation plc is a pharmaceutical company that engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers.
It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.
Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
AMRN is the stock ticker for Amarin Corporation plc and is currently priced at $14.43 per share. It ranks 3525 by market capitalization, with a market cap of $302.58M. The near-term setup reflects mixed signals, while the longer-run forecast points to meaningful upside potential.
A major floor 8.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 4.7% above — a clean break opens room to run.
A major ceiling 13.7% above — clearing it would confirm fresh momentum.
Key AMRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.41 | Buy | $14.42 | Buy |
| MA 10 | $14.45 | Buy | $14.45 | Buy |
| MA 20 | $14.52 | Buy | $14.50 | Buy |
| MA 50 | $14.57 | Sell | $14.61 | Sell |
| MA 100 | $14.80 | Sell | $14.78 | Sell |
| MA 200 | $15.44 | Sell | $14.76 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.96 | Neutral |
| Stoch RSI (14) | 54.03 | Neutral |
| CCI (20) | 0.77 | Neutral |
| Williams %R (14) | -53.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -3.52 | Sell |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 47.00 | Neutral |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 46.69 | Neutral |
| Momentum (10) | -0.43 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 14.45 | Buy |
| ADX (14) | 9.10 | Neutral |
| ATR (14) | 0.20 | Info |
The near-term picture shows BEARISH sentiment with RSI14 at 50. Price action sits around the SMA50 of $14.61 and the SMA200 of $15.45. The key near-term support is at $13.93 and resistance at $15.20. The 30-day range spans from $13.01 to $16.01, and the stock exhibits annualized volatility of 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.50 | $14.52 | $20.06 | 0% | Neutral | |
| $14.99 | $18.35 | $23.51 | +26% | Bullish | |
| $15.69 | $19.55 | $25.71 | +35% | Bullish | |
| $16.14 | $20.42 | $27.41 | +41% | Bullish | |
| $16.73 | $21.45 | $29.30 | +48% | Bullish | |
| $18.62 | $24.17 | $33.53 | +66% | Bullish | |
| $20.58 | $27.01 | $37.99 | +86% | Bullish | |
| $23.40 | $31.02 | $44.20 | +114% | Bullish | |
| $26.04 | $34.87 | $50.27 | +140% | Bullish | |
| $26.29 | $35.54 | $51.80 | +145% | Bullish | |
| $38.38 | $54.09 | $82.59 | +273% | Bullish | |
| $63.38 | $95.80 | $156.75 | +560% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.50 | $14.52 | $17.06 | +0.00% |
| June 2026 | $13.04 | $15.22 | $18.09 | +4.79% |
| July 2026 | $13.20 | $15.48 | $18.59 | +1.77% |
| August 2026 | $13.03 | $15.35 | $18.56 | -0.84% |
| September 2026 | $13.23 | $15.65 | $19.03 | +1.90% |
| October 2026 | $13.61 | $16.15 | $19.75 | +3.23% |
| November 2026 | $13.59 | $16.18 | $19.88 | +0.19% |
| December 2026 | $13.62 | $16.26 | $20.06 | +0.47% |
Click any year to see its month-by-month AMRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AMRN to range from $13.50 to $20.06 through 2026. The $14.52 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AMRN price prediction for 2027 points to an average of $18.35 (low $14.99, high $23.51) — a potential gain of +26% on today's $14.52. Momentum favours further upside here.
In 2028, AMRN is projected to trade between $15.69 and $25.71, averaging $19.55 — a potential gain of +35% from today's $14.52. That is up +7% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Amarin Corporation plc's 2029 outlook centres on $20.42, within a $16.14 to $27.41 range. That is up +4% on the projected 2028 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2030, AMRN could reach as high as $29.30, with a base case around $21.45 and support toward $16.73 — roughly +48% from $14.52. Buyers look set to stay in control over this stretch.
Expect AMRN to range from $18.62 to $33.53 through 2031. The $24.17 average target implies a +66% move from current prices. That is up +13% on the projected 2030 average. Momentum favours further upside here.
The AMRN price prediction for 2032 points to an average of $27.01 (low $20.58, high $37.99) — a potential gain of +86% on today's $14.52. Buyers look set to stay in control over this stretch.
In 2033, AMRN is projected to trade between $23.40 and $44.20, averaging $31.02 — a potential gain of +114% from today's $14.52. That is up +15% on the projected 2032 average. Momentum favours further upside here.
Amarin Corporation plc's 2034 outlook centres on $34.87, within a $26.04 to $50.27 range. That is up +12% on the projected 2033 average. That marks a +140% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AMRN could reach as high as $51.80, with a base case around $35.54 and support toward $26.29 — roughly +145% from $14.52. Momentum favours further upside here.
Expect AMRN to range from $38.38 to $82.59 through 2040. The $54.09 average target implies a +273% move from current prices. That is up +52% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AMRN price prediction for 2050 points to an average of $95.80 (low $63.38, high $156.75) — a potential gain of +560% on today's $14.52. Momentum favours further upside here.
Investing $1,000 in AMRN today (≈ 68.870523 AMRN) could be worth
$6,597.65
+$5,597.65 (+560%) by 2050 · US Dollar
Based on the average projected AMRN price of $95.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMRNwould be worth at today's price.
$1,000 invested in AMRN on May 27, 2025 (≈ 88.028172 AMRN) would be worth
$1,278.17
+$278.17 (+27.8%) today · 1.28× · US Dollar
Based on a AMRN entry price of $11.36 vs. today's $14.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.27 | $1,017.52 | +1.8% |
| 1 month ago | $13.93 | $1,042.35 | +4.2% |
| 3 months ago | $14.12 | $1,028.33 | +2.8% |
| 6 months ago | $15.97 | $909.2 | -9.1% |
| 1 year ago | $11.36 | $1,278.17 | +27.8% |
| All time (5.0y) ago | $92 | $157.83 | -84.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMRN forecast.
Our base-case forecast reaches $29.00 around 2033.
Implied market cap at $29.00: $608.1M
Looking out over the multi-year forecast, the path is bullish from 2027 onward. The 2026 forecast shows min $13.50, avg $14.43, max $20.01 with ROI 0 and sentiment NEUTRAL. In 2027 the avg rises to $18.25 with ROI 26.5 and sentiment BULLISH.
By 2030 the avg is $21.16 with ROI 46.6 and sentiment BULLISH. The progression continues with 2031 ($23.55, ROI 63.2), 2032 ($26.42, ROI 83.1), 2033 ($30.29, ROI 109.9), 2034 ($33.85, ROI 134.6), and 2035 ($34.66, ROI 140.2) all labeled BULLISH. The forecast extends to 2040 with avg $52.03 (ROI 260.6) and to 2050 with avg $92.45 (ROI 540.6).
The max forecast reaches $151.28 in 2050. These are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast shows an avg of $21.16 with min $16.50 and max $28.91, ROI 46.6, and sentiment BULLISH.
The outlook is bullish from 2027 onward, with rising averages (2027 $18.25; 2028 $19.19; 2029 $20.15; 2030 $21.16) and a 2050 max of $151.28, ROI 540.6.
Yes. The forecast max is $151.28 in 2050, which is above $100.
Current price is $14.43. The 30-day range is $13.01 to $16.01, with RSI 50, SMA50 $14.61, SMA200 $15.45, support $13.93, and resistance $15.20.
Market cap is $302.58M and rank is 3525.
Amarin Corporation plc Community Discussion
0Share your Amarin Corporation plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.